Daily Archives: January 12, 2018

Hisense TV sales leads China market for 14 consecutive years

BEIJING, Jan. 12, 2018 /PRNewswire/ — According to the latest data from CMM, Hisense TV ranked No.1 on both retail value and volume for 14 consecutive years in China by the end of 2017. The retail volume of Hisense TV has reached 16.79%. And the retail value of Hisense TV achieved 17.96% in Chinese market, which is significantly more than the brand in second place by 26.5%.

In the international market, Hisense TV performed even better. According to China’s Customs data, Hisense TV’s exports were up to 30.8% YoY by the end of November, 2017, which was way above industry average. From January to October 2017, the unit share of Hisense TV was up to 22.4% in South Africa and reached 19.6% in Australia, ranked first locally.

Against the backdrop of fierce competition in the TV market, Hisense refuses to follow the trend of competing at compromising on quality and price. Instead, Hisense insists on technology innovation and high-quality standards. Through continuous efforts in innovative and differentiated products such as 4K laser TV, U9 ULED TV and VIDAA artificial intelligence system, Hisense is gaining more and more market share. According to CMM’s report, Hisense’s 55-inch 4K TV has won the first in the annual TV sales list in China. Besides, Hisense has gained 4 places in the top 20 list and has become the brightest star in the honor list.

DSM Sinochem Pharmaceuticals successfully launches Rosuvastatin finished dosage formulation in Western Europe

Rijswijk, Netherlands, Jan. 12, 2018 (GLOBE NEWSWIRE) — Upon patent expiry at the end of December 2017, DSM Sinochem Pharmaceutical (DSP) has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries. The successful launch will be extended to additional countries prior to the end of January, among which is the Netherlands.

 After being one of the first companies globally to receive a CEP in early 2016 for Rosuvastatin API, DSP again proves to be a frontrunner by being one of the first to launch Rosuvastatin drug products in Western Europe using its in-house produced API.

Statins are currently the most prescribed drug class globally for high cholesterol and cardiovascular diseases and are among the top selling drugs worldwide. Rosuvastatin is used for reducing high cholesterol and preventing cardiovascular disease, which is the number one cause of death worldwide.

 Quality, Reliability and Sustainability

In line with its brand promise of Quality, Reliability and Sustainability, DSP’s Rosuvastatin offers customers superior performance in all three areas. For its finished dosage formulations, DSP uses its own in-house manufactured API. This proprietary, backward integrated, process, which is protected by 10 patent families, involves a highly efficient enzymatic coupling step, and offers customers independence from third party intermediate suppliers. Additional advantages to its API include unrivalled product quality with an assay of >99% and large batch sizes of 200 kg. This further results in significantly reduced Quality Assurance and testing costs, the absence of hazardous residual chemicals and a 35% reduced carbon footprint related to production.

Expanding portfolio

With the successful launch of the Rosuvastatin finished dosage formulation, on top of the earlier successful launch of DSP’s beta lactam drug products, and the upcoming launch of Atorvastatin in Europe by summer 2018, the company is quickly expanding its drug product portfolio. What sets DSP apart from competitors is its backward integration and full control of its supply chain.

CEO, Karl Rotthier: “I am proud that our company, together with our partners, is among the first worldwide to launch a generic Rosuvastatin finished dosage formulation in Western Europe upon patent expiration; after being one of the first to offer the Rosuvastatin API under CEP. This shows our dedication to excellence and our aspiration to continue to be an industry leader”.

BU Director Drug Products, Lucas Wiarda: “As with every one of our products, Rosuvastatin delivers superior performance on quality, reliability and sustainability compared to the industry average. This is largely due to DSP’s full control of its manufacturing process from start to finish. Building on our strong position in beta lactams, Rosuvastatin is an excellent addition to our drug products portfolio which we proudly offer to our customers.”

Currently DSP holds an eCTD dossier for Rosuvastatin finished dosage formulations (5,10,20 & 40mg FCT) containing Zone II & IV stability data and a 36 month shelf life.

About DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next-generation statins and anti-fungals. DSP develops, produces and sells intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting-edge generics solutions that help to keep customers ahead of the competition.

Headquartered in Singapore, the group has manufacturing sites and sales offices in China, India, Egypt, the Netherlands, Spain, the USA and Mexico. DSP is a 50/50 Joint Venture of Royal DSM, a global science-based company active in health, nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.

For more information please visit www.dsm-sinochem.com or contact DSM Sinochem Pharmaceuticals Corporate Communications, Erin van Wijngaarden, Manager PR & Corporate Communications. E-Mail: communications@dsm-sinochem.com

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7ac00118-d5bc-405d-a32d-b02d5c584c11

Erin van Wijngaarden
DSM Sinochem Pharmaceuticals
communications@dsm-sinochem.com

Arctech Solar’s First Middle East Project to Facilitate Local Seawater Desalination Development

SHANGHAI, Jan. 12, 2018 /PRNewswire/ — At the very beginning of 2018, Arctech Solar’s client formally began the construction work for its 10MW solar power plant in Khafji, Saudi Arabia. This is a new market breakthrough for Arctech Solar’s trackers after its successful entry into the African market last October.

The 10MW Khafji project is expected to be commissioned by the end of March 2018. Once completed, this project can not only produce enough electricity to households, but also power seawater desalting plants nearby with clean, renewable solar power. Given that the project was located in a sandy area, Arctech Solar supplied its redundancy design to this project. With the reliability of its redundancy design and excellent tracking performance, Arctracker Pro was the first tracker product in China that obtained the UL2703 & UL3703 certificates by UL last year and has been widely recognized and accepted by customers.

“We are delighted to make an effort to the development of Saudi Arabia’s seawater desalination,” commented Mr. Guy Rong, president of Arctech Solar’s international business. “This project in Saudi Arabia lays the groundwork for us to enter the Middle East market. We look forward to playing a positive role in ‘Saudi Vison 2030’ and continuing our involvement in the Middle East area.”

Arctech Solar will bring its new product ‘SkySmart’, the world’s first tracker designed for bifacial modules, to the 2018 WFES held in Abu Dhabi on 15th-18th January. We warmly invite you to visit our booth, 8230, and take a closer look at SkySmart.

About Arctech Solar

Arctech Solar is one of the world’s leading manufacturers and solution providers of solar tracking and racking systems. In the past 9 years, Arctech Solar has successfully set up overseas subsidiaries/service centers in America, India, Japan, Spain and Mexico. As of the end of 2017, Arctech Solar has cumulatively installed 13.5GW capacity and completed 800 projects in 15 countries. With a production capacity of 6GW and 3GW in fixed mounting structure and tracker field respectively (a total annual capacity of 9GW), Arctech Solar is now a reliable partner in the global PV Tracking and Racking industry.

For more information please visit: www.arctechsolar.com

For product sales and other enquiries: sales@arctechsolar.com

Press Contact:
Sabrina Lyu
Telephone: +86-150-0085-3002
Email Address: sabrina.lu@arctechsolar.com

شركة تانلا سوليوشنز الرائدة في الهند تعتمد التحويلات الدولية عبر الرسائل النصية القصيرة

حيدرآباد، الهند، 11 يناير 2018/ PRNewswire-FirstCall/ — أعلنت تانلا سوليوشنز “Tanla Solutions“، واحدة من أكبر مقدمي خدمات الاتصالات السحابية في العالم، تجري ما يزيد عن 90 مليار معاملة تجارية عبر الاتصالات سنويًا، عن إطلاق مركزها الدولي للرسائل النصية بمشاركة إحدى شركات المحمول الرائدة في الهند.https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_u47gklae/def_height/400/def_width/400/version/100011/type/1

(الشعار: http://mma.prnewswire.com/media/627459/Tanla_Solutions_Logo.jpg)

يعد مركز الرسائل منصة غنية ومتكاملة ومتماثلة تنظيميًا وضعت ونشرت في وقت قياسي؛ تديرها تانلا لاستثمارات الرسائل القصيرة الدولية. توفر المنصة جدار حماية شامل للرسائل النصية، وخدمة النقل وإنهاء الخدمة عبر وصلة واحدة إلى محور مركزي مخصص في شبكة الاتصالات.

ويعمل الجيل الجديد من منصات تانلا للرسائل النصية المركزية والتي تدعمها شبكة الاتصالات الأفضل في فئتها، على تحسين تجربة العملاء بشكل كبير من خلال سرعة تسليم الرسائل. وتضمن استعلامات المنصة تحديد أولويات التسليم الوقتي للرسائل الحساسة والرسائل الفورية، مما أدى إلى زيادة مضاعفة في معدلات التحويل من المعاملات وعمليات استحواذ المستخدم.

وصرح رئيس مجلس إدارة ومدير شركة تانلا، أوداي ريدي “Uday Reddy” قائلًا: “مع نشر مركز الرسائل النصية الدولية طويلة المدى، تمكنت تانلا وشريكتنا تيلكو “Telco” من توفير خدمة فعالة من حيث التكلفة وخلق نظام فعال لخدمة تسليم الرسائل وبالتالي خلق قيمة أقوى للشركات وتوفير خبرة غنية للمشتركين في الخدمة”.

ومن المتوقع أن يزيد مركز الرسائل النصية الدولية طويلة المدى من تعزيز وضع شركتي تانلا وتلكو في السوق، وتحسين موارد الشبكة وعمل إيرادات إضافية من حركة الرسائل القصيرة الدولية التي تصب في الهند.

نبذة عن شركة تانلا:

بدأت شركة تانلا رحلتها مع الألفية الجديدة بالاستعانة بمجموعة صغيرة من خبراء المراسلة المتنقلة، مع قاعدة في حيدر أباد، الهند، لإنشاء خدمة الرسائل على مستوى عالمي.

اليوم، تانلا هي الشركة الرائدة عالميا في مجالها باعتبارها واحدة من أكبر مقدمي خدمات الاتصالات السحابية، والتعامل مع أكثر من 90 مليار اتصال يتعلق بالمعاملات التجارية سنويًا.

تقوم شركة تانلا بتطوير طريقة التواصل العالمي، ورفع مستوى الخدمات باستمرار من خلال تعزيز سرعة وسهولة وبساطة حلول الاتصالات السحابية، واعتماد التكنولوجيات المتطورة لتلبية الاحتياجات المتزايدة للعملاء المختلفين، من الشركات إلى الموزعين المناطق الجغرافية.

تانلا هي شركة محدودة عامة مدرجة في البورصات الهندية الرائدة (كود الشركة في بورصة بومباي: 532790  وفي البورصة الوطنية للهند: TANLA)

المصدر: Tanla Solutions Limited

UAE, WHO sign healthcare cooperation agreement for mothers and newborns in Yemen

The Ministry of Foreign Affairs and International Cooperation, has signed a cooperation agreement with the World Health Organisation (WHO) to support emergency care for mothers and newborns in the Al Mukalla province in Yemen’s Hadramout governorate, as part of efforts to ensure access to essential and life-saving emergency services for the displaced and their host communities.

The agreement was signed by Sultan Mohammed Al Shamsi, Assistant Minister of Foreign Affairs and International Cooperation for International Development Affairs, in the presence of Obaid Salem Saeed Al Zaabi, Ambassador, Permanent Representative of the United Arab Emirates to the United Nations Office and other international organisations in Geneva, and Dr. Peter Salama, Executive Director of the WHO Health Emergencies Programme.

Under the Cooperation Agreement, the UAE Government, through the Ministry of Foreign Affairs, will grant the WHO US$ 800,000 to implement this humanitarian project in Yemen.

Al Zaabi stressed that this project stems from the keenness of the UAE’s leadership to provide relief support to the Yemeni people, with the total humanitarian assistance so far provided by the UAE to Yemen reaching $ 2.56 billion.

The Ambassador reiterated the UAE’s keenness to strengthen cooperation and partnership with the World Health Organisation in various health fields.

Dr. Salama in turn praised the UAE’s pioneering role in the humanitarian field throughout the world, especially in Yemen, stressing the importance of strengthening UAE-WHO cooperation in order to alleviate the suffering of underprivileged people, save lives, and

Source: UAE MINISTRY OF FOREGIN AFFAIRS

His Highness Sheikh Mohamed bin Zayed receives a call from Italian Prime Minister.

His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, received on Thursday a telephone call from Prime Minister of Italy, Paolo Gentiloni.

They discussed ways to strengthen ties of friendship and cooperation to serve the mutual interests of the two countries They also reviewed the latest regional and international developments and a number of issues of mutual interest.

Source: UAE MINISTRY OF FOREGIN AFFAIRS

Qatar Informs UN About Second Emirates Military Airliner Violating Its Airspace

The State of Qatar has sent two messages to the United Nations Secretary-General and to the President of the Security Council on a UAE military airliner flying from the airspace of the United Arab Emirates to the Kingdom of Bahrain, violating the airspace of the State of Qatar at 10:10 am, Wednesday, January 3 2018.

In a letter sent by the Permanent Mission of the State of Qatar to the United Nations, HE Ambassador Sheikha Alia Ahmed bin Saif Al-Thani, Permanent Representative of the State of Qatar to the United Nations, drew the attention of the Secretary-General of the United Nations and the President of the Security Council to a UAE military airlift carrying induction code (DHC 6) coming from the UAE airspace bound for the Kingdom of Bahrain to enter the airspace of the State of Qatar, at 10:10 am, on Wednesday, January 3 2018 , flying over the Special Economic Zone of the State of Qatar, without prior authorization of the competent Qatari authorities.

Source: MINISTRY OF FOREGIN AFFAIRS